Poly Medicure Limited

Poly Medicure Limited (POLYMED) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

polymedicure.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1768.70
Market cap
17,921 Cr
Stock P/E
61.4
P/B
5.69
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales337 Cr340 Cr378 Cr385 Cr420 Cr424 Cr441 Cr403 Cr444 Cr494 Cr535 Cr525 Cr
Operating expenses (approx.)253 Cr249 Cr281 Cr281 Cr305 Cr310 Cr321 Cr297 Cr329 Cr382 Cr424 Cr400 Cr
EBITDA84 Cr90 Cr97 Cr104 Cr115 Cr115 Cr119 Cr106 Cr115 Cr111 Cr110 Cr125 Cr
OPM %25.0%26.6%25.5%27.0%27.5%27.0%27.1%26.3%25.8%22.5%20.7%23.8%
Other income14 Cr17 Cr15 Cr17 Cr26 Cr22 Cr24 Cr42 Cr34 Cr26 Cr18 Cr33 Cr
Interest2 Cr3 Cr3 Cr3 Cr3 Cr3 Cr2 Cr3 Cr3 Cr6 Cr6 Cr7 Cr
Depreciation16 Cr16 Cr16 Cr20 Cr21 Cr22 Cr21 Cr23 Cr25 Cr29 Cr38 Cr36 Cr
Profit before tax81 Cr88 Cr92 Cr98 Cr118 Cr113 Cr123 Cr123 Cr122 Cr98 Cr85 Cr117 Cr
Tax %23.2%26.0%26.1%24.8%25.9%24.7%25.2%24.3%24.6%27.5%23.7%27.3%
Net profit62 Cr65 Cr68 Cr74 Cr87 Cr85 Cr92 Cr93 Cr92 Cr71 Cr65 Cr85 Cr
EPS (₹)₹6.48₹6.78₹7.12₹7.71₹9.01₹8.48₹8.92₹9.19₹9.06₹7.00₹6.54₹8.49

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales611 Cr687 Cr786 Cr923 Cr1,115 Cr1,376 Cr1,670 Cr1,875 CrSign in for TTM
Operating expenses (approx.)481 Cr523 Cr572 Cr710 Cr850 Cr1,018 Cr1,217 Cr1,433 CrSign in for TTM
EBITDA129 Cr164 Cr214 Cr213 Cr265 Cr358 Cr453 Cr442 CrSign in for TTM
OPM %21.2%23.9%27.3%23.1%23.8%26.0%27.1%23.6%Sign in for TTM
Other income18 Cr18 Cr18 Cr38 Cr36 Cr59 Cr89 Cr120 CrSign in for TTM
Interest12 Cr18 Cr9 Cr4 Cr9 Cr11 Cr12 Cr18 CrSign in for TTM
Depreciation37 Cr41 Cr48 Cr54 Cr57 Cr64 Cr83 Cr116 CrSign in for TTM
Profit before tax100 Cr126 Cr180 Cr195 Cr237 Cr344 Cr453 Cr427 CrSign in for TTM
Tax %34.6%23.7%24.5%25.0%24.5%25.0%25.2%25.0%Sign in for TTM
Net profit65 Cr96 Cr136 Cr147 Cr179 Cr258 Cr339 Cr321 CrSign in for TTM
EPS (₹)₹7.41₹10.86₹15.25₹15.28₹18.69₹26.92₹34.13₹31.79Sign in for TTM
Dividend payout %———16.3%13.4%11.1%9.0%11.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital44 Cr44 Cr48 Cr48 Cr48 Cr48 Cr51 Cr51 Cr
Reserves337 Cr391 Cr918 Cr1,040 Cr1,194 Cr1,422 Cr2,715 Cr3,055 Cr
Borrowings137 Cr168 Cr102 Cr125 Cr146 Cr170 Cr178 Cr342 Cr
Other liabilities136 Cr165 Cr156 Cr164 Cr189 Cr218 Cr249 Cr428 Cr
Total liabilities654 Cr767 Cr1,224 Cr1,377 Cr1,577 Cr1,859 Cr3,192 Cr3,919 Cr
Fixed assets (net)261 Cr312 Cr374 Cr439 Cr587 Cr819 Cr1,038 Cr1,255 Cr
CWIP9 Cr17 Cr15 Cr37 Cr73 Cr67 Cr90 Cr91 Cr
Investments11 Cr29 Cr359 Cr350 Cr127 Cr168 Cr1,077 Cr755 Cr
Loans & advances0.23 Cr0.14 Cr0.33 Cr0.34 Cr0.30 Cr0.23 Cr0.33 Cr0.74 Cr
Inventories84 Cr112 Cr126 Cr168 Cr209 Cr221 Cr286 Cr434 Cr
Trade receivables128 Cr127 Cr156 Cr207 Cr235 Cr270 Cr350 Cr531 Cr
Cash & bank4 Cr5 Cr5 Cr8 Cr7 Cr12 Cr9 Cr51 Cr
Other assets156 Cr165 Cr188 Cr168 Cr339 Cr302 Cr343 Cr801 Cr
Total assets654 Cr767 Cr1,224 Cr1,377 Cr1,577 Cr1,859 Cr3,192 Cr3,919 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———123 Cr191 Cr266 Cr241 Cr241 Cr
Cash from investing———-85 Cr-179 Cr-241 Cr-1,191 Cr-225 Cr
Cash from financing———-35 Cr-13 Cr-20 Cr953 Cr20 Cr
Net cash flow———3 Cr-0.69 Cr5 Cr3 Cr37 Cr
Free cash flow (OCF − Capex)———-32 Cr-48 Cr-11 Cr-84 Cr-68 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.6%23.9%17.7%18.3%17.7%21.7%15.8%12.8%
ROE %0.0%23.5%27.1%13.5%14.4%17.6%12.2%10.2%
Debtor days77687281777276103
Inventory days156182173174179174182263
Days payable104108889279755574
Cash conversion cycle129142157163177170203292
Debt / equity0.000.000.000.000.120.120.060.11
Current ratio1.961.614.123.462.752.405.183.37
Net debt / EBITDA0.000.000.000.000.530.440.370.66

Compare with peers

Loading peers…